CALR and rheumatoid arthritis: Moreover, although native CRT has been described as an autoantigen in several autoimmune conditions (30, 31), its role as a target of autoreactive B cells in RA has only very recently been investigated, with the demonstration that around 60% of RA patients display circulating anti–cit-CRT Abs (32).